Cost of Revenue in USD of Twist Bioscience Corp from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Twist Bioscience Corp quarterly/annual Cost of Revenue history and change rate from 2017 to Q3 2025.
  • Twist Bioscience Corp Cost of Revenue for the quarter ending 30 Sep 2025 was $48.2M, a 3.65% increase year-over-year.
  • Twist Bioscience Corp Cost of Revenue for the twelve months ending 30 Sep 2025 was $186M, a 3.31% increase year-over-year.
  • Twist Bioscience Corp annual Cost of Revenue for 2025 was $186M, a 3.31% increase from 2024.
  • Twist Bioscience Corp annual Cost of Revenue for 2024 was $180M, a 15.6% increase from 2023.
  • Twist Bioscience Corp annual Cost of Revenue for 2023 was $155M, a 30.2% increase from 2022.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

Twist Bioscience Corp Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $186M $48.2M +$1.7M +3.65% 01 Jul 2025 30 Sep 2025 10-K 17 Nov 2025
Q2 2025 $184M $44.8M -$1.43M -3.1% 01 Apr 2025 30 Jun 2025 10-Q 04 Aug 2025
Q1 2025 $185M $46.8M +$2.35M +5.28% 01 Jan 2025 31 Mar 2025 10-Q 05 May 2025
Q4 2024 $183M $45.9M +$3.34M +7.85% 01 Oct 2024 31 Dec 2024 10-Q 03 Feb 2025
Q3 2024 $180M $46.5M +$4.05M +9.55% 01 Jul 2024 30 Sep 2024 10-K 17 Nov 2025
Q2 2024 $176M $46.2M +$4.35M +10.4% 01 Apr 2024 30 Jun 2024 10-Q 04 Aug 2025
Q1 2024 $171M $44.4M +$2.75M +6.6% 01 Jan 2024 31 Mar 2024 10-Q 05 May 2025
Q4 2023 $168M $42.5M +$13.1M +44.5% 01 Oct 2023 31 Dec 2023 10-Q 03 Feb 2025
Q3 2023 $155M $42.4M +$10.8M +34.3% 01 Jul 2023 30 Sep 2023 10-K 17 Nov 2025
Q2 2023 $145M $41.8M +$10.9M +35.1% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024
Q1 2023 $134M $41.7M +$12M +40.2% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024
Q4 2022 $122M $29.4M +$2.39M +8.82% 01 Oct 2022 31 Dec 2022 10-Q 02 Feb 2024
Q3 2022 $119M $31.6M +$9.09M +40.4% 01 Jul 2022 30 Sep 2022 10-K 18 Nov 2024
Q2 2022 $110M $31M +$10M +48% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 $100M $29.7M +$10.7M +56.2% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q4 2021 $89.5M $27.1M +$8.89M +49% 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023
Q3 2021 $80.6M $22.5M +$4.92M +28% 01 Jul 2021 30 Sep 2021 10-K 21 Nov 2023
Q2 2021 $75.7M $20.9M +$4.46M +27.1% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 $71.2M $19M +$5.46M +40.3% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022
Q4 2020 $65.8M $18.2M +$4.37M +31.7% 01 Oct 2020 31 Dec 2020 10-Q 09 Feb 2022
Q3 2020 $61.4M $17.6M +$5.19M +41.9% 01 Jul 2020 30 Sep 2020 10-K/A 05 Jun 2023
Q2 2020 $56.2M $16.5M +$5.08M +44.6% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 $51.1M $13.6M +$1.78M +15.1% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 $49.4M $13.8M +$1.94M +16.3% 01 Oct 2019 31 Dec 2019 10-Q 09 Feb 2021
Q3 2019 $47.4M $12.4M +$3.29M +36.2% 01 Jul 2019 30 Sep 2019 10-K 23 Nov 2021
Q2 2019 $44.1M $11.4M +$3.89M +51.9% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 $40.2M $11.8M +$3.69M +45.6% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 $36.5M $11.9M +$4.36M +58.1% 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020
Q3 2018 $32.2M $9.09M 01 Jul 2018 30 Sep 2018 10-K 27 Nov 2020
Q2 2018 $7.5M 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 $8.1M 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019
Q4 2017 $7.5M 01 Oct 2017 31 Dec 2017 10-Q 11 Feb 2019

Twist Bioscience Corp Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $186M +$5.95M +3.31% 01 Oct 2024 30 Sep 2025 10-K 17 Nov 2025
2024 $180M +$24.2M +15.6% 01 Oct 2023 30 Sep 2024 10-K 17 Nov 2025
2023 $155M +$36.1M +30.2% 01 Oct 2022 30 Sep 2023 10-K 17 Nov 2025
2022 $119M +$38.7M +48% 01 Oct 2021 30 Sep 2022 10-K 18 Nov 2024
2021 $80.6M +$19.2M +31.3% 01 Oct 2020 30 Sep 2021 10-K 21 Nov 2023
2020 $61.4M +$14M +29.5% 01 Oct 2019 30 Sep 2020 10-K/A 05 Jun 2023
2019 $47.4M +$15.2M +47.3% 01 Oct 2018 30 Sep 2019 10-K 23 Nov 2021
2018 $32.2M +$8.17M +34% 01 Oct 2017 30 Sep 2018 10-K 27 Nov 2020
2017 $24M 01 Oct 2016 30 Sep 2017 10-K 13 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.